首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1672128

全球癌症恶病质市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Cancer Cachexia Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球癌症恶病质市场规模预计将从 2024 年的 29 亿美元增长到 2033 年的 46.2 亿美元，在 2026 年至 2033 年的预测期内呈现 5.34% 的强劲年复合成长率(CAGR)。

癌症恶病质市场有望实现大幅增长，这得益于癌症发病率的不断上升以及人们对恶病质作为与癌症相关的严重併发症的认识不断提高。癌症恶病质是一种多因素综合征，其特征是体重严重减轻、肌肉萎缩和整体健康状况下降，严重影响患者的生活品质和治疗结果。随着医疗保健提供者和研究人员认识到解决癌症治疗中恶病质的重要性，对有效治疗和管理策略的需求预计将上升，从而使该市场实现强劲扩张。目前的治疗方案包括营养干预、药物治疗和旨在改善食慾和肌肉量的支持性护理措施。

此外，对癌症恶病质的潜在机制的研究和理解的进步正在推动市场创新。与恶病质有关的特定生物标记和通路的识别为开发更有效地治疗这种疾病的标靶疗法铺平了道路。例如，抗发炎剂和合成代谢类固醇的探索作为潜在的治疗选择正在获得关注。随着研究不断揭示恶病质生物学的新见解，在改善患者预后和生活品质的推动下，市场可能会进一步扩大。

此外，对癌症治疗多学科方法的日益重视正在塑造癌症恶病质的格局。随着医疗保健提供者越来越认识到将营养支持、物理治疗和心理护理整合到癌症治疗计划中的重要性，对全面恶病质管理解决方案的需求可能会增加。这一趋势在个人化医疗的背景下尤其重要，客製化的干预措施可以显着提高癌症治疗的效果。随着癌症恶病质市场不断发展，创新治疗方案、对整体患者护理的关注以及持续的研究将在推动其未来成长方面发挥关键作用。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 9 章：癌症恶病质公司的竞争格局

癌症恶病质市场竞争
伙伴关係/合作/协议
合併与收购
新产品发布
其他进展

第十章：公司简介

顶级公司市占率分析
市场集中度
Aeterna Zentaris Inc.

公司概况
公司收入
产品
最新动态

Alder BioPharmaceuticals Inc.

公司概况
公司收入
产品
最新动态

Aphios Corporation

公司概况
公司收入
产品
最新动态

Eli Lilly And Company

公司概况
公司收入
产品
最新动态

GTxInc.

公司概况
公司收入
产品
最新动态

Helsinn Group

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Bristol-Myers Squibb Company

公司概况
公司收入
产品
最新动态

XBiotech Inc

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR11214594

Global Cancer Cachexia Market size is anticipated to grow from USD 2.9 Billion in 2024 to USD 4.62 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.34% during the forecast period of 2026 to 2033.

The cancer cachexia market is poised for significant growth, driven by the increasing prevalence of cancer and the rising awareness of cachexia as a serious complication associated with the disease. Cancer cachexia is a multifactorial syndrome characterized by severe weight loss, muscle wasting, and a decline in overall health, significantly impacting patients' quality of life and treatment outcomes. As healthcare providers and researchers recognize the importance of addressing cachexia in cancer care, the demand for effective therapies and management strategies is expected to rise, positioning this market for robust expansion. Current treatment options include nutritional interventions, pharmacological agents, and supportive care measures aimed at improving appetite and muscle mass.

Moreover, advancements in research and understanding of the underlying mechanisms of cancer cachexia are driving innovation within the market. The identification of specific biomarkers and pathways involved in cachexia is paving the way for the development of targeted therapies that can more effectively address this condition. For instance, the exploration of anti-inflammatory agents and anabolic steroids is gaining traction as potential treatment options. As research continues to uncover new insights into the biology of cachexia, the market is likely to expand further, driven by the promise of improved patient outcomes and quality of life.

Additionally, the growing emphasis on multidisciplinary approaches to cancer care is shaping the cancer cachexia landscape. As healthcare providers increasingly recognize the importance of integrating nutritional support, physical therapy, and psychological care into cancer treatment plans, the demand for comprehensive cachexia management solutions is likely to increase. This trend is particularly relevant in the context of personalized medicine, where tailored interventions can significantly enhance the effectiveness of cancer therapies. As the cancer cachexia market continues to evolve, the combination of innovative treatment options, a focus on holistic patient care, and ongoing research will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Therapeutics

Progestogens
Corticosteroids
Combination Therapies
Others

By Mechanism of Action

Appetite Stimulators
Weight Loss Stabilizers
Others

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANCER CACHEXIA INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapeutics
- 3.7.2 Market Attractiveness Analysis By Mechanism of Action
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY THERAPEUTICS

5.1. Overview By Therapeutics
5.2. Historical and Forecast Data Analysis By Therapeutics
5.3. Progestogens Historic and Forecast Sales By Regions
5.4. Corticosteroids Historic and Forecast Sales By Regions
5.5. Combination Therapies Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY MECHANISM OF ACTION

6.1. Overview By Mechanism of Action
6.2. Historical and Forecast Data Analysis By Mechanism of Action
6.3. Appetite Stimulators Historic and Forecast Sales By Regions
6.4. Weight Loss Stabilizers Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Stores Historic and Forecast Sales By Regions
7.4. Retail Pharmacy Stores Historic and Forecast Sales By Regions
7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL CANCER CACHEXIA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER CACHEXIA COMPANIES

9.1. Cancer Cachexia Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CANCER CACHEXIA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Aeterna Zentaris Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Alder BioPharmaceuticals Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Aphios Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Eli Lilly And Company
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. GTxInc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Helsinn Group
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Merck & Co. Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Novartis AG
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Bristol-Myers Squibb Company
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. XBiotech Inc
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Therapeutics (USD MN)
Progestogens Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Combination Therapies Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Mechanism of Action (USD MN)
Appetite Stimulators Market Sales By Geography (USD MN)
Weight Loss Stabilizers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Stores Market Sales By Geography (USD MN)
Retail Pharmacy Stores Market Sales By Geography (USD MN)
Online Pharmacies Market Sales By Geography (USD MN)
Global Cancer Cachexia Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cancer Cachexia Report
Market Research Process
Market Research Methodology
Global Cancer Cachexia Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Therapeutics
Market Attractiveness Analysis By Mechanism of Action
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Therapeutics (USD MN)
Progestogens Market Sales By Geography (USD MN)
Corticosteroids Market Sales By Geography (USD MN)
Combination Therapies Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Mechanism of Action (USD MN)
Appetite Stimulators Market Sales By Geography (USD MN)
Weight Loss Stabilizers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Stores Market Sales By Geography (USD MN)
Retail Pharmacy Stores Market Sales By Geography (USD MN)
Online Pharmacies Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.